MedWatch

Novo Nordisk allies with Bluebird Bio to develop gene therapies

Novo Nordisk has started to collaborate with the American superstar biotech company Bluebird Bio to develop gene therapies for hemophilia and other genetic diseases.

Novo Nordisk Photo: Novo Nordisk/ PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles